Bezlotoxumab during the first episode of Clostridioides difficile infection in patients at high risk of recurrence

被引：0

作者：

Rosa Escudero-Sanchez

Antonio Ramos-Martínez

Antonio F. Caballero-Bermejo

Beatriz Díaz-Pollán

Guillermo Ruiz-Carrascoso

María Olmedo Samperio

Patricia Muñoz García

Paloma Merino Amador

Fernando González Romo

Oriol Martín Segarra

Gema Navarro Jiménez

Laura del Campo Albendea

Alfonso Muriel García

Javier Cobo

机构：

[1] Ramon y Cajal University Hospital,Infectious Disease Department

[2] Instituto de Salud Carlos III (IRYCIS),Center for Biomedical Research in Infectious Diseases Network (CIBERINFEC)

[3] Instituto de Salud Carlos III,Internal Medicine Department

[4] University Hospital Puerta de Hierro-Majadahonda,Pharmacology Department

[5] University Hospital Puerta de Hierro-Majadahonda,Infectious Diseases Unit, Internal Medicine Department

[6] La Paz University Hospital,Microbiology Department

[7] La Paz Institute for Health Research (IdiPAZ),Microbiology and Infectious Disease Department

[8] La Paz University Hospital,Microbiology Department

[9] Gregorio Marañón University Hospital,Infectious Disease Department

[10] Clínico San Carlos University Hospital,Biostatistics Unit

[11] Fundación Alcorcon University Hospital,undefined

[12] University Hospital Ramon y Cajal,undefined

[13] Biomedical Research Networking Center for Epidemiology and Public Health (CIBERESP),undefined

[14] Universidad de Alcalá,undefined

来源：

European Journal of Clinical Microbiology & Infectious Diseases | 2024年 / 43卷

关键词：

Bezlotoxumab; infection; Recurrence;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：533 / 540

页数：7

共 50 条

[1] Bezlotoxumab during the first episode of Clostridioides difficile infection in patients at high risk of recurrence
Escudero-Sanchez, Rosa
Ramos-Martinez, Antonio
Caballero-Bermejo, Antonio F.
Diaz-Pollan, Beatriz
Ruiz-Carrascoso, Guillermo
Samperio, Maria Olmedo
Garcia, Patricia Munoz
Amador, Paloma Merino
Romo, Fernando Gonzalez
Segarra, Oriol Martin
Jimenez, Gema Navarro
Albendea, Laura del Campo
Garcia, Alfonso Muriel
Cobo, Javier
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2024, 43 (03) : 533 - 540
[2] Risk factors of first recurrence of Clostridioides difficile infection
Yokoyama, Yuki
Shiota, Arufumi
Asai, Nobuhiro
Koizumi, Yusuke
Yamagishi, Yuka
Sakanashi, Daisuke
Nakamura, Akiko
Suematsu, Hiroyuki
Ohnishi, Masafumi
Mikamo, Hiroshige
ANAEROBE, 2022, 75
[3] Real-World Comparison of Bezlotoxumab to Standard of Care Therapy for Prevention of Recurrent Clostridioides difficile Infection in Patients at High Risk for Recurrence
Johnson, Tanner M.
Molina, Kyle C.
Howard, Amanda H.
Schwarz, Kerry
Allen, Lorna
Huang, Misha
Bajrovic, Valida
Miller, Matthew A.
CLINICAL INFECTIOUS DISEASES, 2022, 74 (09) : 1572 - 1578
[4] EFFICACY OF BEZLOTOXUMAB IN CANCER PATIENTS WITH RECURRENT CLOSTRIDIOIDES DIFFICILE INFECTION
Mazhuvanchery, Cyril
Naz, Sidra
Varatharajalu, Krishnavathana
Okhuysen, Pablo C.
Wang, Yinghong
GASTROENTEROLOGY, 2023, 164 (06) : S696 - S697
[5] Bezlotoxumab in Patients with a Primary Clostridioides difficile Infection: A Literature Review
Granata, Guido
Schiavone, Francesco
Pipitone, Giuseppe
ANTIBIOTICS-BASEL, 2022, 11 (11):
[6] Real-World Experience with Bezlotoxumab for Prevention of Recurrence of Clostridioides difficile Infection
Escudero-Sanchez, Rosa
Ruiz-Ruigomez, Maria
Fernandez-Fradejas, Jorge
Garcia Fernandez, Sergio
Olmedo Samperio, Maria
Cano Yuste, Angela
Valencia Alijo, Angela
Diaz-Pollan, Beatriz
Rodriguez Hernandez, Maria Jesus
Merino De Lucas, Esperanza
Martin Segarra, Oriol
Saez Bejar, Carmen
Arminanzas Castillo, Carlos
Gutierrez-Gutierrez, Belen
Rodriguez-Pardo, Dolors
Ramos-Martinez, Antonio
Torre-Cisneros, Julian
Lopez-Medrano, Francisco
Cobo Reinoso, Javier
JOURNAL OF CLINICAL MEDICINE, 2021, 10 (01) : 1 - 9
[7] Rate of Utilization of Bezlotoxumab for Prevention of Clostridioides difficile Infection Recurrence in a Community Hospital
Nayeem, Mohammed Mustafa
Tawfik, Mena
Singh, Rajiv
Patel, Uday
Sammar, Aleena
Firdous, Nida
Patel, Jatinbhai
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S1276 - S1276
[8] Fidaxomicin monotherapy versus standard therapy combined with bezlotoxumab for treating patients with Clostridioides difficile infection at high risk of recurrence: a matched cohort study
Escudero-Sanchez, Rosa
Muriel Garcia, Alfonso
Garcia Fernandez, Sergio
Valencia Alijo, Angela
Tasias Pitarch, Mariona
Merino De Lucas, Esperanza
Gutierrez Rojas, Angela
Ramos Martinez, Antonio
Salavert Lleti, Miguel
Giner, Livia
Ruiz Ruigomez, Maria
Garcia Basas, Lorena
Fernandez Fradejas, Jorge
Olmedo Sampedrio, Maria
Cano Yuste, Angela
Diaz Pollan, Beatriz
Rodriguez Hernandez, Maria Jesus
Martin Segarra, Oriol
Saez Bejar, Carmen
Arminanzas Castillo, Carlos
Gutierrez, Belen
Rodriguez-Pardo, Dolors
De La Torre Cisneros, Julian
Lopez Medrano, Francisco
Cobo Reinoso, Javier
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2022, 77 (07) : 1996 - 2002
[9] Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection in Patients at Increased Risk for Recurrence
Gerding, Dale N.
Kelly, Ciaran P.
Rahav, Galia
Lee, Christine
Dubberke, Erik R.
Kumar, Princy N.
Yacyshyn, Bruce
Kao, Dina
Eves, Karen
Ellison, Misoo C.
Hanson, Mary E.
Guris, Dalya
Dorr, Mary Beth
CLINICAL INFECTIOUS DISEASES, 2018, 67 (05) : 649 - 656
[10] Efficacy of bezlotoxumab in preventing the recurrence of Clostridioides difficile infection: an Italian multicenter cohort study
Meschiari, Marianna
Cozzi-Lepri, Alessandro
Cervo, Adriana
Granata, Guido
Rogati, Carlotta
Franceschini, Erica
Casolari, Stefania
Tatarelli, Paola
Giacobbe, Daniele Roberto
Bassetti, Matteo
Pinna, Simone Mornese
De Rosa, Francesco Giuseppe
Barchiesi, Francesco
Canovari, Benedetta
Lorusso, Carolina
Russo, Giuseppe
Cenderello, Giovanni
Cascio, Antonio
Petrosillo, Nicola
Mussini, Cristina
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2023, 131 : 147 - 154

← 1 2 3 4 5 →